AI Article Synopsis

  • The study investigates the effectiveness of diffusion-weighted imaging (DWI) and T-weighted imaging (TWI) in detecting prostate cancer, focusing on the impact of high b-values (> 1000 s/mm) through a systematic review and meta-analysis.
  • A total of 33 studies involving 2,949 patients were analyzed, revealing a pooled sensitivity of 69% and specificity of 84%, with improved sensitivity associated with high b-values.
  • The findings suggest that while the combined use of DWI and TWI shows good diagnostic accuracy, more extensive research on b-values is needed to make definitive recommendations.

Article Abstract

Purpose: This study aims to investigate the role of diffusion-weighted imaging (DWI) and T-weighted imaging (TWI) in combination for the detection of prostate cancer, specifically assessing the role of high b-values (> 1000 s/mm), with a systematic review and meta-analysis of the existing published data.

Methods: The electronic databases MEDLINE, EMBASE, and OpenSIGLE were searched between inception and September 1, 2017. Eligible studies were those that reported the sensitivity and specificity of DWI and TWI for the diagnosis of prostate cancer by visual assessment using a histopathologic reference standard. The QUADAS-2 critical appraisal tool was used to assess the quality of included studies. A meta-analysis with pooling of sensitivity, specificity, likelihood, and diagnostic odds ratios was undertaken, and a summary receiver-operating characteristics (sROC) curve was constructed. Predetermined subgroup analysis was also performed.

Results: Thirty-three studies were included in the final analysis, evaluating 2949 patients. The pooled sensitivity and specificity were 0.69 (95% CI 0.68-0.69) and 0.84 (95% CI 0.83-0.85), respectively, and the sROC AUC was 0.84 (95% CI 0.81-0.87). Subgroup analysis showed significantly better sensitivity with high b-values (> 1000 s/mm). There was high statistical heterogeneity between studies.

Conclusion: The diagnostic accuracy of combined DWI and TWI is good with high b-values (> 1000 s/mm) seeming to improve overall sensitivity while maintaining specificity. However, further large-scale studies specifically looking at b-value choice are required before a categorical recommendation can be made.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061488PMC
http://dx.doi.org/10.1007/s00261-017-1400-4DOI Listing

Publication Analysis

Top Keywords

prostate cancer
12
high b-values
12
b-values > 1000 s/mm
12
sensitivity specificity
12
diagnostic accuracy
8
t-weighted imaging
8
detection prostate
8
dwi twi
8
subgroup analysis
8
084 95%
8

Similar Publications

Purpose: To evaluate evidence on germline and somatic genomic testing for patients with metastatic prostate cancer and provide recommendations.

Methods: A systematic review by a multidisciplinary panel with patient representation was conducted. The PubMed database was searched from January 2018 to May 2024.

View Article and Find Full Text PDF

Adult Embryonal Rhabdomyosarcoma of the Prostate Presented on 18F-FDG and Al18F-FAPI-74 PET/CT.

Clin Nucl Med

December 2024

From the Department of Nuclear Medicine (PET-CT Center), National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

A 21-year-old man with a 2-week history of abdominal pain and urinary hesitancy was admitted to our hospital. Sarcoma was suspected based on his PSA level, age, and MRI findings. He underwent 18F-FDG and Al18F-FAPI-74 PET/CT scans.

View Article and Find Full Text PDF

Purpose: Advanced prostate cancer (PCa) is invariably fatal with the androgen receptor (AR) being a major therapeutic target. AR signaling inhibitors have improved overall survival for men with advanced PCa, but treatment resistance is inevitable and includes reactivation of AR signaling. Novel therapeutic approaches targeting these mechanisms to block tumor growth is an urgent unmet clinical need.

View Article and Find Full Text PDF

Background: Sex hormone-binding globulin (SHBG) plays a critical role in regulating androgen bioavailability and has been hypothesized to influence prostate cancer risk, though existing evidence is inconsistent. This systematic review and meta-analysis aimed to evaluate the association between SHBG levels and prostate cancer risk.

Methods: A comprehensive search was conducted across PubMed, Embase, and Web of Science for studies published up to December 1, 2024.

View Article and Find Full Text PDF

Prostate cancer is a significant global health issue due to its high incidence and poor outcomes in metastatic disease. This study aims to develop models predicting overall survival for patients with metastatic biochemically recurrent prostate cancer, potentially helping to identify high-risk patients and enabling more tailored treatment options. A multi-centre cohort of 180 such patients underwent [Ga]Ga-PSMA-11 PET/CT scans, with lesions semi-automatically segmented and radiomic features extracted from lesions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!